H. Gelderblom

Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.

S. Sleijfer, F. van Coevorden, H. Gelderblom, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

CLINICAL Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up † the ESMO Guidelines Committee and EURACAN*

E. Álava, A. Cesne, H. Joensuu, 2020 .

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Litière, A. Cesne, H. Joensuu, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Bevacizumab Treatment for Patients with NF2-Related Schwannomatosis: A Single Center Experience

E. Hensen, Jules P J Douwes, J. C. Jansen, 2024, Cancers.

Extremely long survival in six patients despite recurrent and metastatic adrenal carcinoma.

J. Kievit, J. Romijn, H. Gelderblom, 2008, European journal of endocrinology.

First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study.

M. van Glabbeke, M. Glabbeke, A. Cesne, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, E. Álava, E. Wardelmann, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

PALETTE: A randomized, double-blind, phase III trial of pazopanib versus placebo in patients (pts) with soft-tissue sarcoma (STS) whose disease has progressed during or following prior chemotherapy-An EORTC STBSG Global Network Study (EORTC 62072).

J. Blay, A. Cesne, A. D. Dei Tos, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients.

H. Putter, R. Tollenaar, J. Nortier, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Monitoring neoadjuvant treatment-induced surgical benefit in GIST patients using CT-based radiological criteria

L. de Geus-Oei, A. J. van der Molen, G. M. Kalisvaart, 2024, Surgery Open Science.

Dose-escalation study using up to twice the standard dose of cetuximab in patients with metastatic colorectal cancer (mCRC) with no or slight skin reactions on cetuximab standard dose treatment (EVEREST study): Preliminary data.

E. Van Cutsem, F. Ciardiello, Y. Humblet, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.